MII (maladie de Crohn/colite)

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » MII (maladie de Crohn/colite)

11. Mai 2021

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 1984


	Articles 1 - 20 / 39662

	Predicting Mucosal Proliferation in Ulcerative Colitis by Assessing Mucosal Vascular Pattern Under Narrow Band Imaging Colonoscopy. Turk J Gastroenterol Guo T, Qian JM, Yang AM, Li Y, Zhou WX. PMID: 33960945 [PubMed - as supplied by publisher]
	Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study. Ann Gastroenterol Grazie ML, Bagnoli S, Dragoni G, Caini S, Annese V, Innocenti T, Deiana S, Manetti N, Milani S, Galli A, Milla M. PMID: 33948062 [PubMed]
	Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial. BMJ Open Janssen L, Romberg-Camps M, van Bodegraven A, Haans J, Aquarius M, Boekema P, Munnecom T, Brandts L, Joore M, Masclee A, Jonkers D, Pierik M. PMID: 33947729 [PubMed - in process]
	Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC). BMC Microbiol Li W, Sun Y, Dai L, Chen H, Yi B, Niu J, Wang L, Zhang F, Luo J, Wang K, Guo R, Li L, Zou Q, Ma ZS, Miao Y. PMID: 33947329 [PubMed - in process]
	Possible Earlier Diagnosis of Ulcerative Colitis-Associated Neoplasia: A Retrospective Analysis of Interval Cases during Surveillance. J Clin Med Hisabe T, Matsui T, Yamasaki K, Morokuma T, Aomi K, Yoshizawa N, Takatsu N, Yao K, Ueki T, Futami K, Tanabe H, Iwashita A. PMID: 33946906 [PubMed]
	The Relationship between Mucins and Ulcerative Colitis: A Systematic Review. J Clin Med Bankole E, Read E, Curtis MA, Neves JF, Garnett JA. PMID: 33946184 [PubMed]
	Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease. Front Pharmacol Wu G, Yang Y, Liu M, Wang Y, Guo Q. PMID: 33935772 [PubMed]
	Ischaemic bowel perforation secondary to a gravid uterus in a patient with treated inflammatory bowel disease and an ileoanal pouch: a case report. Ann R Coll Surg Engl Wasson E, Jones MJ, Fazili N, Burn P, Nagabushanam S, Vickery C, Ryan N. PMID: 33930284 [PubMed - indexed for MEDLINE]
	Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis. Exp Biol Med (Maywood) Zhang L, Ma X, Liu P, Ge W, Hu L, Zuo Z, Xiao H, Liao W. PMID: 33926254 [PubMed - as supplied by publisher]
	The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD138) in Patients with Crohn's Disease and Ulcerative Colitis. J Clin Med Derkacz A, Olczyk P, Jura-Pó, Olczyk K, Komosinska-Vassev K. PMID: 33923501 [PubMed]
	Chronic Inflammation Impairs Male Fertility-A Case-Control Study in Ulcerative Colitis Patients. J Clin Med Wdowiak A, Gujski M, Bojar I, Raczkiewicz D, Bartosi, Wdowiak-Filip A, Filip R. PMID: 33918143 [PubMed]
	One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study. Aliment Pharmacol Ther Dhaliwal J, McKay HE, Deslandres C, Debruyn J, Wine E, Wu A, Huynh H, Carman N, Crowley E, Church PC, Walters TD, Ricciuto A, Griffiths AM, Canadian Children IBD Network.. PMID: 33909911 [PubMed - as supplied by publisher]
	BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION. Arq Gastroenterol Queiroz NSF, Teixeira FV, Freire CCF, Motta MP, Vasconcellos MAM, Chebli LA, Saad-Hossne R, Brazilian Inflamatory Bowel Diseases Study Group (GEDIIB) COVID taskforce.. PMID: 33909805 [PubMed - indexed for MEDLINE]
	BODY IRON STATUS INDICATORS AND INFLAMMATION INDICATORS DURING INFLAMMATORY BOWEL DISEASE THERAPY IN CHILDREN AND ADOLESCENTES. Arq Gastroenterol Corrêa FF, Sdepanian VL. PMID: 33909796 [PubMed - indexed for MEDLINE]
	CORRELATION BETWEEN TROUGH LEVELS OF INFLIXIMAB AND POSTOPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE PATIENTS SUBMITTED TO ILEOCOLONIC RESECTIONS: A SYSTEMATIC REVIEW. Arq Gastroenterol Baraúna FDSB, Kotze PG. PMID: 33909788 [PubMed - indexed for MEDLINE]
	Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study. J Crohns Colitis Straatmijer T, Biemans VBC, Hoentjen F, de Boer NKH, Bodelier AGL, Dijkstra G, van Dop WA, Haans JJL, Jansen JM, Maljaars PWJ, van der Marel S, Oldenburg B, Ponsioen CY, Visschedijk MC, de Vries AC, West RL, van der Woude CJ, Pierik M, Duijvestein M, van der Meulen-de Jong AE. PMID: 33909062 [PubMed - as supplied by publisher]
	Interleukin 6: biological significance and role in inflammatory bowel diseases. Adv Clin Exp Med Paw, Krawiec P, Pac-Ko. PMID: 33908198 [PubMed - indexed for MEDLINE]
	A study on the potential role of autophagy-related protein 10 as a biomarker for ulcerative colitis. Physiol Rep Abbasi Teshnizi F, Kazemipour N, Nazifi S, Bagheri Lankarani K, Sepehrimanesh M, Razeghian Jahromi I. PMID: 33904657 [PubMed - in process]
	Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis. Inflamm Bowel Dis Hyams JS, Brimacombe M, Haberman Y, Walters T, Gibson G, Mo A, Mack D, Griffiths A, Boyle B, LeLeiko N, Markowitz J, Rosh J, Patel A, Shah S, Baldassano R, Pfefferkorn M, Sauer C, Dailey J, Venkateswaran S, Kugathasan S, Denson LA. PMID: 33904583 [PubMed - as supplied by publisher]
	[Strategies for discontinuing immunotherapy in patients with inflammatory bowel disease]. MMW Fortschr Med Stange EF. PMID: 33904098 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39662

Page 1 de 1984



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité